A Prospective, non-interventional study evaluating cognitive performance in relapsing remitting MS patients treated with dimethylfumarate -a two-year longitudinal study
Latest Information Update: 22 Jan 2020
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 22 Jan 2020 New trial record